About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
Join Now
Utah Life Sciences News & Events
Corporate Policy and Infectious Disease Response Plan
March 25, 2020
Develop an overriding policy for how the company will respond to a COVID-19 outbreak and impacts. Helpful resources:
Click here
to download a copy of the World Health Organization’s guide to developing a “Strategic Preparedness and Response Plan for the New Coronavirus”
CDC Business and Employer Guidance
Implement a plan of action for counseling employees who are concerned they may have been exposed to the virus.
Identify an HR point of contact
Where to send them to get tested (
https://coronavirus.utah.gov.
)
Policy for self-quarantine
Tracing of exposure to others
Clarify PTO and sick leave policies to encourage employees who are not well to stay home. Paid sick leave should be adjusted to accommodate the response to COVID-19.
Understand that employees may be affected by school closures that will impact child care needs and employee availability.
Plan for business disruptions
Cross Train employees
Identify critical functions to maintain operations.
Examine supply chain vulnerabilities.
Establish a process to communicate information to employees on the company response plan
Coordination with state and local health officials is strongly suggested to ensure appropriate and timely actions and responses.
Recent News
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Springboard Enterprises Announces 2026 Women’s Health Accelerator Cohort
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Utah’s Life Sciences Community Takes Off at the 2026 Entrepreneur & Investor Summit
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG